Brazilian researchers have developed a synthetic compound that has the potential to treat malaria and block its transmission.

Advances in vaccine technology, antibody therapies, and genetic surveillance are giving researchers new tools to fight ...

Almost all the drugs that are widely used today against Plasmodium spp., the causative agent of malaria, target the asexual blood stages of the parasite. Widespread drug resistance severely restricts ...

A new approach to antimalarial development, aided by high-throughput screening, could help to overcome resistance.

Malaria is caused by a eukaryotic microbe of the Plasmodium genus, and is responsible for more deaths than all other parasitic diseases combined. In order to transmit from the human host to the ...

(RTTNews) - QIAGEN N.V. (QGEN) has unveiled the QIAprep& Plasmodium Kit along with two companion assays to enhance efforts in malaria research and monitoring. This innovative solution streamlines ...

Research could pave the way to new anti-malarials that work by “jet-lagging” the parasites that cause the disease. DURHAM, N.C. -- Health officials warn that drug resistance could wipe out recent ...

Diagnosis of Plasmodium falciparum malaria using rapid diagnostic tests and treatment with artemisinin derivatives, the main component of the malaria treatments recommended by the World Health ...

The parasites that cause malaria may march to the beat of their own drum. A malarial infection is a series of cyclical symptoms. Depending on the Plasmodium species involved, fever and chills return ...